The pooled HR for OS shows that FHIT hypermethylation is associated with worsen survival in NSCLC patients as shown in Fig. 7 (HR = 1.73, 95% CI = 1.10–2.71, p  = 0.02). This evidence concerns the gene FHIT and non-small cell lung carcinoma.